ERBB2 and posterior cortical atrophy: PCa resistance to therapy is associated with abnormally increased expression of AR, Bcl-2, erbB, HER2 (human epidermal growth factor receptor 2), cyclin D1, and cyclooxygenase (COX-2), all of which are associated with the activation of transcription nuclear factor NF-κB.